Q4 2023 13F Holders as of 12/31/2023
-
Type / Class
-
Equity / Common Stock
-
Shares outstanding
-
28.4M
-
Number of holders
-
532
-
Total 13F shares, excl. options
-
24.6M
-
Shares change
-
+806K
-
Total reported value, excl. options
-
$7.54B
-
Value change
-
+$282M
-
Put/Call ratio
-
0.67
-
Number of buys
-
269
-
Number of sells
-
-211
-
Price
-
$306.53
Significant Holders of Medpace Holdings, Inc. - Common Stock (MEDP) as of Q4 2023
587 filings reported holding MEDP - Medpace Holdings, Inc. - Common Stock as of Q4 2023.
Medpace Holdings, Inc. - Common Stock (MEDP) has 532 institutional shareholders that have filed 13F forms with the Securities Exchange Commission (SEC).
These institutions hold a total of 24.6M shares
of 28.4M outstanding shares and own 86.55% of the company stock.
Largest 10 shareholders include VANGUARD GROUP INC (2.56M shares), BlackRock Inc. (2.42M shares), WASATCH ADVISORS LP (1.19M shares), Invesco Ltd. (723K shares), RIVERBRIDGE PARTNERS LLC (684K shares), STATE STREET CORP (671K shares), GEODE CAPITAL MANAGEMENT, LLC (493K shares), Boston Trust Walden Corp (488K shares), TD ASSET MANAGEMENT INC (467K shares), and FULLER & THALER ASSET MANAGEMENT, INC. (445K shares).
This table shows the top 532 institutional shareholders of the company equity. This data is sourced directly from the SEC via 13F filings.
| Investor |
Option |
Weight % |
Change % |
Value $ |
* Price $ |
Shares |
Share Change |
Activity |
Report Period |
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.